MDCT anatomic assessment of right inferior phrenic artery origin related to potential supply to hepatocellular carcinoma and its embolization

Cardiovasc Intervent Radiol. 2008 Mar-Apr;31(2):349-58. doi: 10.1007/s00270-007-9236-x. Epub 2007 Dec 11.

Abstract

Purpose: To prospectively assess the anatomic variation of the right inferior phrenic artery (RIPA) origin with multidetector computed tomography (MDCT) scans in relation to the technical and angiographic findings during transcatheter arterial embolization of hepatocellular carcinoma (HCC).

Methods: Two hundred patients with hepatocellular carcinomas were examined with 16-section CT during the arterial phase. The anatomy of the inferior phrenic arteries was recorded, with particular reference to their origin. All patients with subcapsular HCC located at segments VII and VIII underwent arteriography of the RIPA with subsequent embolization if neoplastic supply was detected.

Results: The RIPA origin was detected in all cases (sensitivity 100%), while the left inferior phrenic artery origin was detected in 187 cases (sensitivity 93.5%). RIPAs originated from the aorta (49%), celiac trunk (41%), right renal artery (5.5%), left gastric artery (4%), and proper hepatic artery (0.5%), with 13 types of combinations with the left IPA. Twenty-nine patients showed subcapsular HCCs in segments VII and VIII and all but one underwent RIPA selective angiography, followed by embolization in 7 cases.

Conclusion: MDCT assesses well the anatomy of RIPAs, which is fundamental for planning subsequent cannulation and embolization of extrahepatic RIPA supply to HCC.

MeSH terms

  • Adult
  • Aged
  • Angiography
  • Carcinoma, Hepatocellular / blood supply*
  • Carcinoma, Hepatocellular / therapy*
  • Chemoembolization, Therapeutic
  • Collateral Circulation
  • Contrast Media
  • Female
  • Humans
  • Liver Neoplasms / blood supply*
  • Liver Neoplasms / therapy*
  • Male
  • Middle Aged
  • Prospective Studies
  • Sensitivity and Specificity
  • Tomography, X-Ray Computed
  • Treatment Outcome

Substances

  • Contrast Media